Akriti Mishra Meza (Akriti Mishra)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Health Insurance

Radical Prostatectomy

Prognostic Factors

Bone Mineral Density

Top Venues

JCO oncology practice

Journal of the National Cancer Institute. Monographs

Prostate cancer and prostatic diseases

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice 20 (3) (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice 20 (3) (2024)
Kaitlyn Lapen, Akriti Mishra Meza, Edward Christopher Dee, Jun J Mao, Nirupa Jaya Raghunathan, Sankeerth Jinna, Jessica Brens, Deborah Korenstein, Helena Furberg-Barnes, Talya Salz, Fumiko L Chino
Patient out-of-pocket costs for cannabis use during cancer treatment. Journal of the National Cancer Institute. Monographs 2024 (66) (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice 20 (3) (2024)
Kaitlyn Lapen, Akriti Mishra Meza, Edward Christopher Dee, Jun J Mao, Nirupa Jaya Raghunathan, Sankeerth Jinna, Jessica Brens, Deborah Korenstein, Helena Furberg-Barnes, Talya Salz, Fumiko L Chino
Patient out-of-pocket costs for cannabis use during cancer treatment. Journal of the National Cancer Institute. Monographs 2024 (66) (2024)
Kaitlyn Lapen, Akriti Mishra Meza, Edward Christopher Dee, Jun J Mao, Nirupa Jaya Raghunathan, Sankeerth Jinna, Jessica Brens, Deborah Korenstein, Helena Furberg-Barnes, Talya Salz, Fumiko L Chino
Patient out-of-pocket costs for cannabis use during cancer treatment. Journal of the National Cancer Institute. Monographs 2024 (66) (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice 20 (3) (2024)
Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, Niti U Trivedi, Aaron N Winn, Aaron N Winn
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study. BMJ (Clinical research ed.) 383 (2023)
Aaron P Mitchell, Akriti Mishra Meza, Katherine S Panageas, Allison Lipitz-Snyderman, Azeez Farooki, Michael J Morris
Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2022)
Amol S Navathe, Joshua M Liao, Kristin A Linn, Yi Zhang, Akriti Mishra Meza, Robin H Wang, Claire T Dinh, Jingsan Zhu, Deborah S Cousins, Jacob Lindner, Ezekiel J Emanuel
Spillover Effects of Medicare's Voluntary Bundled Payments for Joint Replacement Surgery to Patients Insured by Commercial Health Plans. Annals of internal medicine 174 (2) (2020)